Literature DB >> 26552646

A Novel Parent Questionnaire for the Detection of Seizures in Children.

Laurie M Douglass1, Karl Kuban2, Daniel Tarquinio3, Leah Schraga4, Rinat Jonas2, Timothy Heeren5, William A DeBassio2, Carl E Stafstrom6, Ryan John Heinrick7, Chantal Ferguson4, Lauren Blumberg4, Vanessa Wong4.   

Abstract

BACKGROUND: We developed a seizure questionnaire that could be administered by a trained research assistant in a two-step process, approximating the clinical diagnostic process of a pediatric epileptologist. This questionnaire was designed to study seizure prevalence in a research population of 10-year-old children at risk for epilepsy.
METHODS: English-speaking parents of children 6 months to 12 years old were recruited from the pediatric neurology clinics at Boston Medical Center and interviewed using a computerized questionnaire. An algorithm of parent responses rendered a 4-level ranking scale of seizure probability for events: (1) not likely, (2) indeterminate, (3) probable, (4) almost certain. Blinded to questionnaire results, pediatric neurologists served as the diagnostic gold standard, ranking each patient event using the same four-level scale based on clinical history and examination.
RESULTS: The questionnaire was completed by 150 of 177 (84.7%) enrolled parents. Seizure prevalence among participants was 38.6%. The seizure questionnaire yielded a fitted receiver operating characteristic area of 0.93 (95% confidence interval [CI], 0.89-0.97). Based on optimal sensitivity and false-positive fraction, we dichotomized the questionnaire results as consistent with seizure (levels 3 and 4) or without seizure (levels 1 and 2). Overall, findings included a 91.4% sensitivity (95% CI, 84.2%-98.6%) and an 82.6% specificity (95% CI, 74.9%-90.4%). The positive predictive value was 76.8% (95% CI, 66.9%-86.8%) and the negative predictive value was 93.8% (95% CI, 88.6%-99.1%).
CONCLUSIONS: This pediatric seizure questionnaire was both sensitive and specific for detecting clinically confirmed seizures. This tool may be useful to researchers and clinicians in screening large populations of children, decreasing the time and cost of added neurological assessments.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  children; epilepsy; parent; pediatric; questionnaire; seizure; survey; validation studies

Mesh:

Year:  2015        PMID: 26552646     DOI: 10.1016/j.pediatrneurol.2015.09.016

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  8 in total

1.  Co-occurrence and Severity of Neurodevelopmental Burden (Cognitive Impairment, Cerebral Palsy, Autism Spectrum Disorder, and Epilepsy) at Age Ten Years in Children Born Extremely Preterm.

Authors:  Rachel G Hirschberger; Karl C K Kuban; Thomas M O'Shea; Robert M Joseph; Tim Heeren; Laurie M Douglass; Carl E Stafstrom; Hernan Jara; Jean A Frazier; Deborah Hirtz; Julie V Rollins; Nigel Paneth
Journal:  Pediatr Neurol       Date:  2017-11-13       Impact factor: 3.372

2.  Cumulative Incidence of Seizures and Epilepsy in Ten-Year-Old Children Born Before 28 Weeks' Gestation.

Authors:  Laurie M Douglass; Timothy C Heeren; Carl E Stafstrom; William DeBassio; Elizabeth N Allred; Alan Leviton; T Michael O'Shea; Deborah Hirtz; Julie Rollins; Karl Kuban
Journal:  Pediatr Neurol       Date:  2017-05-18       Impact factor: 3.372

3.  Antecedents of epilepsy and seizures among children born at extremely low gestational age.

Authors:  Rachana Singh; Laurie M Douglass; T Michael O'Shea; Carl E Stafstrom; Elizabeth N Allred; Stephen Engelke; Bhavesh Shah; Alan Leviton; Timothy C Hereen; Karl C K Kuban
Journal:  J Perinatol       Date:  2019-03-27       Impact factor: 2.521

4.  Girls and Boys Born before 28 Weeks Gestation: Risks of Cognitive, Behavioral, and Neurologic Outcomes at Age 10 Years.

Authors:  Karl C K Kuban; Robert M Joseph; Thomas M O'Shea; Elizabeth N Allred; Timothy Heeren; Laurie Douglass; Carl E Stafstrom; Hernan Jara; Jean A Frazier; Deborah Hirtz; Alan Leviton
Journal:  J Pediatr       Date:  2016-03-19       Impact factor: 4.406

5.  Epilepsy surveillance in normocephalic children with and without prenatal Zika virus exposure.

Authors:  Karen Blackmon; Randall Waechter; Barbara Landon; Trevor Noël; Calum Macpherson; Tyhiesia Donald; Nikita Cudjoe; Roberta Evans; Kemi S Burgen; Piumi Jayatilake; Vivian Oyegunle; Otto Pedraza; Samah Abdel Baki; Thomas Thesen; Dennis Dlugos; Geetha Chari; Archana A Patel; Elysse N Grossi-Soyster; Amy R Krystosik; A Desiree LaBeaud
Journal:  PLoS Negl Trop Dis       Date:  2020-11-30

6.  Neonatal Cranial Ultrasound Findings among Infants Born Extremely Preterm: Associations with Neurodevelopmental Outcomes at 10 Years of Age.

Authors:  Heather Campbell; Jennifer Check; Karl C K Kuban; Alan Leviton; Robert M Joseph; Jean A Frazier; Laurie M Douglass; Kyle Roell; Elizabeth N Allred; Lynn Ansley Fordham; Stephen R Hooper; Hernan Jara; Nigel Paneth; Irina Mokrova; Hongyu Ru; Hudson P Santos; Rebecca C Fry; T Michael O'Shea
Journal:  J Pediatr       Date:  2021-06-04       Impact factor: 6.314

7.  Health and Development at Age 19-24 Months of 19 Children Who Were Born with Microcephaly and Laboratory Evidence of Congenital Zika Virus Infection During the 2015 Zika Virus Outbreak - Brazil, 2017.

Authors:  Ashley Satterfield-Nash; Kim Kotzky; Jacob Allen; Jeanne Bertolli; Cynthia A Moore; Isabela Ornelas Pereira; André Pessoa; Flavio Melo; Ana Carolina Faria E Silva Santelli; Coleen A Boyle; Georgina Peacock
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-12-15       Impact factor: 17.586

8.  Functional Outcomes among a Cohort of Children in Northeastern Brazil Meeting Criteria for Follow-Up of Congenital Zika Virus Infection.

Authors:  Jeanne Bertolli; Jacob Elijah Attell; Charles Rose; Cynthia A Moore; Flávio Melo; Jennifer Erin Staples; Kim Kotzky; Nevin Krishna; Ashley Satterfield-Nash; Isabela Ornelas Pereira; André Pessoa; Donna Camille Smith; Ana Carolina Faria E Silva Santelli; Coleen A Boyle; Georgina Peacock
Journal:  Am J Trop Med Hyg       Date:  2020-05       Impact factor: 2.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.